1. Home
  2. PGEN vs IRMD Comparison

PGEN vs IRMD Comparison

Compare PGEN & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$97.93

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
IRMD
Founded
1998
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PGEN
IRMD
Price
$4.76
$97.93
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$7.67
$72.00
AVG Volume (30 Days)
3.8M
75.0K
Earning Date
03-18-2026
02-05-2026
Dividend Yield
N/A
0.69%
EPS Growth
N/A
13.00
EPS
N/A
1.65
Revenue
$6,309,000.00
$80,511,268.00
Revenue This Year
$342.78
$15.17
Revenue Next Year
$478.46
$10.15
P/E Ratio
N/A
$60.01
Revenue Growth
59.20
12.91
52 Week Low
$1.11
$47.48
52 Week High
$5.23
$104.93

Technical Indicators

Market Signals
Indicator
PGEN
IRMD
Relative Strength Index (RSI) 58.07 46.60
Support Level $4.37 $96.46
Resistance Level $4.88 $100.44
Average True Range (ATR) 0.40 2.92
MACD 0.01 -0.70
Stochastic Oscillator 71.03 17.09

Price Performance

Historical Comparison
PGEN
IRMD

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: